APA

Anjomshoa M., Hadadzadeh H., Torkzadeh-Mahani M., Fatemi S. J., Adeli-Sardou M., Rudbari H. A. & Nardo V. M. (20160216). A mononuclear Cu(II) complex with 5,6-diphenyl-3-(2-pyridyl)-1,2,4-triazine: Synthesis, crystal structure, DNA- and BSA-binding, molecular modeling, and anticancer activity against MCF-7, A-549, and HT-29 cell lines. : European journal of medicinal chemistry.

Chicago

Anjomshoa Marzieh, Hadadzadeh Hassan, Torkzadeh-Mahani Masoud, Fatemi Seyed Jamilaldin, Adeli-Sardou Mahboubeh, Rudbari Hadi Amiri and Nardo Viviana Mollica. 20160216. A mononuclear Cu(II) complex with 5,6-diphenyl-3-(2-pyridyl)-1,2,4-triazine: Synthesis, crystal structure, DNA- and BSA-binding, molecular modeling, and anticancer activity against MCF-7, A-549, and HT-29 cell lines. : European journal of medicinal chemistry.

Harvard

Anjomshoa M., Hadadzadeh H., Torkzadeh-Mahani M., Fatemi S. J., Adeli-Sardou M., Rudbari H. A. and Nardo V. M. (20160216). A mononuclear Cu(II) complex with 5,6-diphenyl-3-(2-pyridyl)-1,2,4-triazine: Synthesis, crystal structure, DNA- and BSA-binding, molecular modeling, and anticancer activity against MCF-7, A-549, and HT-29 cell lines. : European journal of medicinal chemistry.

MLA

Anjomshoa Marzieh, Hadadzadeh Hassan, Torkzadeh-Mahani Masoud, Fatemi Seyed Jamilaldin, Adeli-Sardou Mahboubeh, Rudbari Hadi Amiri and Nardo Viviana Mollica. A mononuclear Cu(II) complex with 5,6-diphenyl-3-(2-pyridyl)-1,2,4-triazine: Synthesis, crystal structure, DNA- and BSA-binding, molecular modeling, and anticancer activity against MCF-7, A-549, and HT-29 cell lines. : European journal of medicinal chemistry. 20160216.